TP53 and neoplasm: Univariate analysis further showed that clinical stage (Stages II/III/IV vs. Stage I), histological grade (G3 vs. G1 & G2), residual tumor (R1 & R2 vs. R0), tumor invasion (%) (≥ 50 vs. < 50), primary therapy outcome [complete remission (CR) vs. PD/SD/PR], histological type (serous vs. endometrioid), TP53 status (Mutant vs. Wildtype), and GGH expression (high vs. low) were significantly correlated with OS, PFI, and DSS (Table 3).